Table 6.
Week 4 BL | Up to Year 1 | Up to Year 2 | Up to Year 3 | Up to Year 4 | Up to Year 5 | |
---|---|---|---|---|---|---|
Modal | ||||||
Mean (SD), mg/kg | 0.66 (0.32) | 0.90 (0.50) | 0.95 (0.52) | 0.96 (0.53) | 0.96 (0.53) | 0.97 (0.53) |
Median, mg/kg | 0.61 | 0.79 | 0.85 | 0.87 | 0.87 | 0.87 |
Q1, Q3 | 0.44, 0.87 | 0.50, 1.18 | 0.51, 1.30 | 0.52, 1.33 | 0.54, 1.36 | 0.54, 1.36 |
Maximum | ||||||
Mean (SD), mg/kg | 0.67 (0.32) | 1.06 (0.57) | 1.14 (0.61) | 1.17 (0.61) | 1.19 (0.62) | 1.19 (0.62) |
Median, mg/kg | 0.61 | 0.96 | 1.00 | 1.06 | 1.07 | 1.07 |
Q1, Q3 | 0.44, 0.88 | 0.62, 1.40 | 0.65, 1.49 | 0.69, 1.58 | 0.69, 1.60 | 0.69, 1.65 |
BL, baseline; Q1, 25th percentile; Q3, 75th percentile; SD, standard deviation.
Two patients received clobazam for <22 days and were excluded from this analysis.
(N = 265)